thymoquinone has been researched along with cordycepin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Cheng, J; Du, J; Fu, J; Fu, S; Guo, K; He, J; He, T; Li, D; Li, T; Liu, S; Liu, X; Liu, Z; Qian, J; Song, B; Tan, Q; Zhang, L; Zhou, B | 1 |
Cheng, J; Fu, J; He, J; Li, T; Liu, S; Liu, X; Liu, Z; Mei, Z; Tan, Q; Wang, K; Wei, C | 1 |
2 other study(ies) available for thymoquinone and cordycepin
Article | Year |
---|---|
Impact of
Topics: Adenosine; COVID-19; COVID-19 Drug Treatment; Humans; Lung Neoplasms; Male; Mutation; Prognosis; Prostatic Neoplasms; SARS-CoV-2; Serine Endopeptidases | 2022 |
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17.
Topics: ADAM17 Protein; Angiotensin-Converting Enzyme 2; Antiviral Agents; COVID-19; Humans; Peptidyl-Dipeptidase A; SARS-CoV-2 | 2022 |